PMID: 3756141Jul 29, 1986Paper

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

Biochemistry
S C BockR Huber

Abstract

The primary structure of human C1 inhibitor was determined by peptide and DNA sequencing. The single-chain polypeptide moiety of the intact inhibitor is 478 residues (52,869 Da), accounting for only 51% of the apparent molecular mass of the circulating protein (104,000 Da). The positions of six glucosamine-based and five galactosamine-based oligosaccharides were determined. Another nine threonine residues are probably also glycosylated. Most of the carbohydrate prosthetic groups (probably 17) are located at the amino-terminal end (residues 1-120) of the protein and are particularly concentrated in a region where the tetrapeptide sequence Glx-Pro-Thr-Thr, and variants thereof, is repeated 7 times. No phosphate was detected in C1 inhibitor. Two disulfide bridges connect cysteine-101 to cysteine-406 and cysteine-108 to cysteine-183. Comparison of the amino acid and cDNA sequences indicates that secretion is mediated by a 22-residue signal peptide and that further proteolytic processing does not occur. C1 inhibitor is a member of the large serine protease inhibitor (serpin) gene family. The homology concerns residues 120 through the C-terminus. The sequence was compared with those of nine other serpins, and conserved and nonconserv...Continue Reading

Citations

Jan 1, 1996·Cytotechnology·P Závodzky, S Cseh
Jan 1, 1992·International Journal of Clinical & Laboratory Research·A AgostoniW Porreca
Jan 1, 1993·Immunologic Research·A R McPhaden, K Whaley
Nov 4, 2005·Springer Seminars in Immunopathology·Marco CicardiBenedetta Cicardi
Jan 22, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·M LenerT Meo
May 31, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·C DrouetM G Colomb
Jan 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·P A PatstonM Schapira
Jan 1, 1987·Pharmacology & Therapeutics·D H Perlmutter, H R Colten
Oct 1, 1995·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Z Liang, K Söderhäll
May 26, 2004·Biochimica Et Biophysica Acta·Ineke G A BosC Erik Hack
Oct 24, 2003·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Alvin E Davis
Feb 20, 2003·Transplantation Proceedings·D FukutaR Shirakura
Sep 5, 2001·Molecular Immunology·A CarugatiM Cicardi
Jul 14, 1999·Molecular Immunology·M Kirschfink, W Nürnberger
May 30, 1997·Biochimica Et Biophysica Acta·J A RussellS Heaphy
Sep 27, 2000·Biochimica Et Biophysica Acta·I Simonovic, P A Patston
Dec 1, 1988·Baillière's Clinical Rheumatology·R D Campbell
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·I Leonard Bernstein
Jan 29, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Tom BowenZhi Yu Xiang
Jul 30, 2002·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Henriette FarkasBeáta Visy
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N J LevyA E Davis
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R B ParadA E Davis
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D Stoppa-LyonnetM Tosi
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M JansonM Nordenskjöld
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Kleniewski, V H Donaldson
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·E VerpyM Tosi
Jun 26, 1989·Nucleic Acids Research·A R McPhadenK Whaley
Nov 12, 2005·Current Opinion in Pediatrics·Michael M Frank
Aug 23, 2002·Protein Science : a Publication of the Protein Society·Thomas SulikowskiPhilip A Patston
Jun 1, 1995·Anaesthesia·M Cox, A Holdcroft
Aug 15, 1998·Vox Sanguinis·S Meri, H Jarva
Dec 15, 1987·European Journal of Biochemistry·C M MackinnonJ E Fothergill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.